GlassScriptPhysician profile
Melody D Randle
NPI 1326462854
$1,075.22
in general payments reported to CMS, 2019-2025
9 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2023: $439 · 2024: $208 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $233.77 | 2023-2024 | Camzyos |
| Irhythm Technologies, INC. | $187.15 | 2023 | Zio Xt Patch |
| Impulse Dynamics (USA) INC. | $132.65 | 2023 | Optimizer |
| Novo Nordisk INC | $124.99 | 2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $124.97 | 2021 | |
| Boston Scientific Corporation | $101.95 | 2025 | Watchman Access System |
| American Regent | $93.93 | 2024 | Injectafer |
| Atricure, INC. | $52.65 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $23.16 | 2025 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Randle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.